Use access key #2 to skip to page content.
$7.49 -0.18 (-2.35%)
1/9/2009 4:00 PM

Syneron Medical Ltd. (ELOS)

CAPS Rating:
*****

The Company designs, develops and markets innovative aesthetic medical products based on its ELOS, technology, which uses the synergy between electrical energy and optical energy to provide effective, safe and affordable aesthetic medical treatments.

View Ticker Page (ELOS)

Results 11 - 20 of 131 :   12345Next »

Recs

1

Avatar nachos4119 (59.82) Submitted: 6/11/07 7:07 PM : Outperform Start Price: $26.03 ELOS Score: -35.05

Out of favor stock at the moment, recently signed a distribution deal with P&G so look for revenue to accelerate when ELOS start selling products with P&G. People will always want to look pretty and that by itself sells

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar crazykling (94.05) Submitted: 10/24/07 11:04 PM : Outperform Start Price: $18.37 ELOS Score: -17.97

ELOS - They make medical devices to help people look young, healthy, etc...

I've been watching this stock ever since my good stock buddy Margersinger turned me onto it over a year ago. He's a great stock picker, but the economist in him is a bit e...

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar pleaseelosplease (25.58) Submitted: 12/07/06 7:59 PM : Outperform Start Price: $23.62 ELOS Score: -31.43

A ton of thoughs at http://retailinvestor.blospot.com - have been very long and very very overweight ELOS for about a year now and am at a point where I am BEGGING this stock to recover - I am pretty confident it will.. just hope it happens sooner th...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar Tanzig (< 20) Submitted: 8/07/07 6:11 PM : Outperform Start Price: $24.35 ELOS Score: -29.27

Syneron sells cosemtic laser products to physisians/meidcal spas etc.. who perform aesthetic treatments to end patients. The market of end patients is growing as the Baby Boomers age and as technology advances to enable more procedures to be safely ...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar shekel4nothing (< 20) Submitted: 6/14/07 6:19 AM : Outperform Start Price: $25.50 ELOS Score: -29.22

Tremendous amount of cash on hand, technological advantage, P&G distribution deal, solid earnings and revenue growth. If they start treating their shareholders better (give back some of that cash!) then this becomes a no brainer.

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar nau99 (87.84) Submitted: 3/10/07 9:11 PM : Outperform Start Price: $25.93 ELOS Score: -34.56

20% revenue growth this year; new partnerships with large-scale consumer companies

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar harrison5048 (< 20) Submitted: 3/28/07 12:38 PM : Outperform Start Price: $27.04 ELOS Score: -34.93

Jumping on the minimally invasive asthetics bandwagon - aging, increasingly vain domestic population, increasing middle class discretionary dollars worldwide. ELOS and CYNO are positioned to profit well.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar TMFHelical (99.02) Submitted: 8/21/07 10:30 PM : Outperform Start Price: $23.63 ELOS Score: -29.91

This is a reasonably priced company growing sales with very nice profitability metrics. It services a burgeoning demographic market (wrinkled boomers).

One of the other pitchers said it well - there is no price on vanity.

Report this Post Replies: 2 | Reply | Permalink

Recs

2

Avatar CL12NK (< 20) Submitted: 10/06/06 3:49 PM : Outperform Start Price: $24.10 ELOS Score: -36.88

Hair-removal, pigment-lightening, leg vein and wrinkle-reduction, skin-tightening, skin-rejuvenation, reduction in appearence of cellulite: all magical words to an increasingly large population. Sure it is a crowded and competitive field, but their i...

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar ABendall (45.08) Submitted: 10/20/06 8:27 PM : Outperform Start Price: $23.02 ELOS Score: -33.85

I ran a stock screen to filter out companies with similar characteristics to C-Trip (CTRP), I then did a discounted cash flow valuation on each of the stocks that were listed and added them to my selections if the valuation was reasonable. This was o...

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links